Experimental Osteomyelitis Caused by Methicillin-Resistant Staphylococcus aureus Treated with a Polylactide Carrier Releasing Linezolid
- 24 February 2011
- journal article
- Published by SAGE Publications in Surgical Infections
- Vol. 12 (2) , 131-135
Abstract
Background: The effectiveness of a new delivery system consisting of polymerized dilactide (PLA) with incorporated linezolid was investigated in a rabbit model as a means of treating methicillin-resistant Staphylococcus aureus (MRSA) osteomyelitis. Methods: The PLA–linezolid system was prepared after thorough stirring of PLA with linezolid at a 10:1 ratio. Experimental osteomyelitis was established in 40 rabbits by a modification of the Norden model with MRSA as the test isolate. After a hole had been drilled in the upper right femur, the isolate was inoculated using a thin needle working as a foreign body. At three weeks, the needle was removed and cultured, and the PLA–linezolid system was implanted in half the animals (group B); the remaining half was the control group (group A). Animals were sacrificed at regular intervals; tissue around the site of implantation was examined for pathologic changes and cultured quantitatively. Results: The prepared system eluted linezolid in vitro at concentrations much greater than the minimum inhibitory concentration (MIC) of the test pathogen for 11 days. At three weeks after inoculation of the test isolate, all animals had osteomyelitis. By the sixth week, bacterial growth from cancellous bone of group B was significantly lower than that in group A. However, this effect was not maintained until the end of the study (weeks 8 and 10), when the differences in bacterial growth in the two groups were not significant. Conclusion: Polymerized dilactide mixed with 10% linezolid achieved partial arrest of the offending pathogen in an experimental model of osteomyelitis caused by MRSA.Keywords
This publication has 13 references indexed in Scilit:
- Local Treatment of Experimental Pseudomonas aeruginosa Osteomyelitis with a Biodegradable Dilactide Polymer Releasing CiprofloxacinAntimicrobial Agents and Chemotherapy, 2008
- Activities of Clindamycin, Daptomycin, Doxycycline, Linezolid, Trimethoprim-Sulfamethoxazole, and Vancomycin against Community-Associated Methicillin-Resistant Staphylococcus aureus with Inducible Clindamycin Resistance in Murine Thigh Infection and In Vitro Pharmacodynamic ModelsAntimicrobial Agents and Chemotherapy, 2008
- Linezolid in the Treatment of Implant-related Chronic OsteomyelitisClinical Orthopaedics and Related Research, 2007
- A Bioresorbable Calcium Phosphate Delivery System with Teicoplanin for Treating MRSA OsteomyelitisClinical Orthopaedics and Related Research, 2004
- Oxazolidinone antibioticsThe Lancet, 2001
- Treatment of experimental osteomyelitis caused by methicillin-resistant Staphylococcus aureus with a biodegradable system of lactic acid polymer releasing pefloxacinJournal of Antimicrobial Chemotherapy, 2000
- Determination of linezolid in plasma by reversed-phase high-performance liquid chromatographyJournal of Pharmaceutical and Biomedical Analysis, 1999
- State‐of‐the‐Art Clinical Article: Pharmacokinetic/Pharmacodynamic Parameters: Rationale for Antibacterial Dosing of Mice and MenClinical Infectious Diseases, 1998
- Characterization of a rabbit model of staphylococcal osteomyelitisJournal of Orthopaedic Research, 1997
- Experimental Osteomyelitis. I. A Description of the ModelThe Journal of Infectious Diseases, 1970